UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach

UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach

The specific protein targets involved in pancreatic cancer (PC) pathogenesis and its varying levels of differentiation remain incompletely understood. Advanced proteomic methodologies provide a powerful means of identifying key regulatory proteins and signaling pathways central to cancer progressio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kongfan Zhu, Hua Hu, Yuanfa Tao, Zhijian Yang, Hanjun Li
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-05-01
Series:	Biomolecules & Biomedicine
Subjects:	Pancreatic cancer PC proteomics differentiated pancreatic cancer target experimental validation
Online Access:	http://www.bjbms.org/ojs/index.php/bjbms/article/view/11958
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proteomics in pancreatic cancer
by: Fei Cai, et al.
Published: (2025-07-01)

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
by: Wasfi Alrawashdeh, et al.
Published: (2019-05-01)

A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer
by: Bruno Bockorny, et al.
Published: (2024-12-01)

CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer
by: Wenfeng Xi, et al.
Published: (2025-04-01)

Structure-based discovery and experimental validation of HIT101481851 as a potential PKMYT1 inhibitor for pancreatic cancer
by: Ting Wang, et al.
Published: (2025-06-01)

Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview
by: David Solil, et al.
Published: (2024-11-01)

The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study
by: Yasemin Pekmezci, et al.
Published: (2025-01-01)

Pancreatic cancer subtyping - the keystone of precision treatment
by: Zeyang Fan, et al.
Published: (2025-04-01)

Impact of Order Set on Exocrine Pancreatic Insufficiency in Chronic Pancreatitis, Pancreatic Cancer, and Pancreatic Resection
by: Michael Ladna, et al.
Published: (2025-01-01)

Inflammatory Stimuli and Fecal Microbiota Transplantation Accelerate Pancreatic Carcinogenesis in Transgenic Mice, Accompanied by Changes in the Microbiota Composition
by: Agnieszka Świdnicka-Siergiejko, et al.
Published: (2025-02-01)

Diagnosis methods for pancreatic cancer with the technique of deep learning: a review and a meta-analysis
by: Yuanbo Bi, et al.
Published: (2025-08-01)

Effect of smoking cessation on the likelihood of pancreatitis and pancreatic cancer
by: Xiao Han, et al.
Published: (2024-07-01)

Pancreatic intraepithelial neoplasia with carcinoma in situ with repeated distally localized pancreatitis: a case report
by: Yoshiaki Tanji, et al.
Published: (2022-01-01)

Prevalence of hypertension, levels of lipids and blood glucose in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer
by: I. N. Grigorieva, et al.
Published: (2020-07-01)

Establishment of nomogram of early death in elderly pancreatic cancer patients with liver metastasis
by: Yang Wu, et al.
Published: (2025-03-01)

Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer
by: Xinqiao Wang, et al.
Published: (2024-12-01)

Progress of Research on Transformation of Chronic Pancreatitis to Cancer
by: Bangwei HUANG, et al.
Published: (2024-12-01)

Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study
by: Nicolò de Pretis, et al.
Published: (2025-07-01)

Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development
by: Laura E. Kane, et al.
Published: (2025-01-01)

Features of immunophenotype of pancreatic ductal adenocarcinoma
by: A. V. Evseyev
Published: (2014-12-01)

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
by: Jordina Rincon-Torroella, et al.
Published: (2025-05-01)

Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
by: Barbara Włodarczyk, et al.
Published: (2020-05-01)

Alcohol promotes CPT1A-induced lipid metabolism disorder to sentinel-regulate acute pancreatitis
by: Zenghui Li, et al.
Published: (2025-01-01)

Pancreatic ductual carcinoma with isolated liver metastases: is it worth performing surgical resection?
by: V. I. Egorov, et al.
Published: (2024-11-01)

Characterization and treatment of brain metastases from pancreatic cancer: a systematic review
by: Yuanchi Ma, et al.
Published: (2025-07-01)

Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
by: Ulrich Nitsche, et al.
Published: (2016-01-01)

Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
by: Zain A. Karamya, et al.
Published: (2024-08-01)

mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
by: Saima Firdaus, et al.
Published: (2025-03-01)

LONG-TERM RESULTS OF SURGICAL TREATMENT FOR PANCREATIC CANCER. A REVIEW OF THE LITERATURE
by: B. N. GURMIKOV, et al.
Published: (2017-06-01)

Administration of aspirin and risk of pancreatic ductal adenocarcinoma
by: Arooba Noor Abbasi, et al.
Published: (2024-12-01)

Isolation of Trypsin from Serum of pancreatic Cancer Patients and determination some biochemical parameters
by: Layla A. Mustafa, et al.
Published: (2023-01-01)

Inhibition of FAK promotes pancreatic cancer immunotherapy by mediating CXCL10 secretion to enhance CD8+ T cell infiltration
by: Yu-Chen Shi, et al.
Published: (2025-12-01)

Extracellular Vesicle‐Packaged Linc‐ZNF25‐1 from Pancreatic Cancer Cell Promotes Pancreatic Stellate Cell Uptake of Asparagine to Advance Chemoresistance
by: Miao Yu, et al.
Published: (2025-04-01)

Clock genes in pancreatic disease progression: from circadian regulation to dysfunction
by: Tiankuo Zheng, et al.
Published: (2025-12-01)

Correlation Between Fatty Pancreas Disease and Pancreatic Diseases, Perioperative Complications of Pancreatic Surgery
by: Wu Z, et al.
Published: (2025-03-01)

Identification of prognostic and therapeutic biomarkers associated with macrophage and lipid metabolism in pancreatic cancer
by: Lili Wu, et al.
Published: (2025-04-01)

The role of tRNA-Derived small RNAs (tsRNAs) in pancreatic cancer and acute pancreatitis
by: Yan Pan, et al.
Published: (2025-04-01)

Triple metachronous primary pancreatic and gallbladder cancer associated with pancreaticobiliary maljunction: a case report
by: Yuta Kuhara, et al.
Published: (2021-04-01)

CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook
by: Hanieh Noormohamadi, et al.
Published: (2025-08-01)

ROLE OF MICROENVIRONMENT IN THE DEVELOPMENT AND PROGRESSION OF PANCREATIC CANCER
by: E. V. Okladnikova, et al.
Published: (2016-07-01)